Brainhole Technology Limited on 16 April 2026 disposed of 3,600 Nasdaq-listed Nebius Group N.V. Class A shares through on-market transactions, realising total proceeds of approximately US$0.60 million (HK$4.50 million) before costs. The average selling price was about US$159.00 (HK$1,237.02) per share.

Including two previous sell-downs completed on 29 October 2025 and 13 March 2026—covering an aggregate 29,500 shares for around US$3.40 million—the company’s cumulative divestment in Nebius over the past 12 months now totals roughly US$4.00 million (HK$31.40 million). Under Hong Kong Listing Rules 14.22 and 14.23, the aggregation lifts the overall transaction to “major” status, as the applicable percentage ratios exceed 25% but remain below 75%.

Post-sale, Brainhole Technology retains 11,000 Nebius shares. Management estimates a disposal gain of about US$0.20 million (HK$1.60 million), calculated as the excess of sale proceeds over the original acquisition cost. The cash proceeds will be earmarked for general working capital and potential future investments.

To satisfy Listing Rule 14.44, majority shareholder Yoho Bravo Limited—holding 74.96% of Brainhole Technology’s issued share capital—has provided written approval for the transaction, obviating the need for an extraordinary general meeting. A circular containing further details will be distributed to shareholders on or before 8 May 2026.

Nebius reported unaudited revenue of US$91.50 million (HK$711.87 million) and a net loss of US$641.40 million (HK$4.99 billion) for FY 2024, improving to revenue of US$529.80 million (HK$4.12 billion) and net profit of US$101.70 million (HK$791.23 million) for FY 2025. Its unaudited consolidated net asset value rose from US$3.25 billion (HK$25.31 billion) at 31 December 2024 to US$4.61 billion (HK$35.89 billion) at 31 December 2025.

Brainhole Technology’s board considers the disposal terms fair and reasonable and in the interests of the company and its shareholders.